- Home
- DUK vs GSK Comparison
DUK vs GSK Comparison
Compare DUK & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUK
- GSK
- Stock Information
- Founded
- DUK 1904
- GSK 1715
- Country
- DUK United States
- GSK United Kingdom
- Employees
- DUK N/A
- GSK N/A
- Industry
- DUK Railroads
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- DUK Industrials
- GSK Health Care
- Exchange
- DUK Nasdaq
- GSK Nasdaq
- Market Cap
- DUK 87.7B
- GSK 76.5B
- IPO Year
- DUK N/A
- GSK N/A
- Fundamental
- Price
- DUK $114.67
- GSK $33.96
- Analyst Decision
- DUK Buy
- GSK Hold
- Analyst Count
- DUK 12
- GSK 5
- Target Price
- DUK $121.73
- GSK $45.50
- AVG Volume (30 Days)
- DUK 3.3M
- GSK 8.4M
- Earning Date
- DUK 11-07-2024
- GSK 10-30-2024
- Dividend Yield
- DUK 3.64%
- GSK 4.58%
- EPS Growth
- DUK 285.29
- GSK N/A
- EPS
- DUK 5.44
- GSK 0.81
- Revenue
- DUK $29,751,000,000.00
- GSK $41,966,224,352.00
- Revenue This Year
- DUK $6.29
- GSK $6.50
- Revenue Next Year
- DUK $4.09
- GSK $4.54
- P/E Ratio
- DUK $21.09
- GSK $20.36
- Revenue Growth
- DUK 3.48
- GSK 5.59
- 52 Week Low
- DUK $89.92
- GSK $32.83
- 52 Week High
- DUK $121.25
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- DUK 52.40
- GSK 31.68
- Support Level
- DUK $109.40
- GSK $33.17
- Resistance Level
- DUK $113.68
- GSK $33.79
- Average True Range (ATR)
- DUK 1.87
- GSK 0.51
- MACD
- DUK 0.30
- GSK -0.09
- Stochastic Oscillator
- DUK 79.97
- GSK 26.75
About DUK Duke Energy Corporation (Holding Company)
Duke Energy is one of the largest us utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to 8.2 million customers. Its natural gas utilities serve more than 1.6 million customers.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.